SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-08-07
👔
Jazz Pharmaceuticals plc
@JAZZ_InsiderForm 4 Filing: Pearce Samantha Surrenders for Taxes $204,063.6 of $JAZZ
TAX WITHHOLDING
⚡ MATERIALITY: 3/10
corporate issuer
Jazz Pharmaceuticals plc
Ticker: $JAZZ
Transaction Value
$204,063.6
Price/Share: $261.62
transaction date
2026-08-05
Shares: 780
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Pearce Samantha, holds the title of EVP, Chief Commercial Officer at Jazz Pharmaceuticals plc.
On 2026-08-05, the insider transacted 780 shares.The shares were transacted at a weighted average price of $261.62 per share, resulting in a total market-relevant value of $204,063.6.
Executive Summary Summary
Pearce Samantha (EVP, Chief Commercial Officer) had withheld for taxes $204K of $JAZZ
Post-Transaction Position: 47,131 shares
SEC Accession No: 0001805688-26-000014 (CIK: 1805688)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.